{"content":"<li class=\"n-box-item date-title\" data-end=\"1408939199\" data-start=\"1408852800\" data-txt=\"Saturday, December 21, 2019\">Sunday, August 24, 2014</li><li class=\"n-box-item sa-box-item\" data-id=\"1950225\" data-ts=\"1408915909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHHBY\" target=\"_blank\">RHHBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1950225-roche-to-buy-intermune-for-8_3b-in-cash\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roche to buy InterMune for $8.3B in cash</a></h4><ul>\n<li>Roche (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a>, <a href=\"https://seekingalpha.com/symbol/RHHBF\" title=\"Roche Holding Ltd\">OTCQX:RHHBF</a>) will pay $74/share for InterMune (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ITMN\" title=\"InterMune, Inc.\">ITMN</a>), a 38% premium to its Friday close and 63% higher than Aug. 12 when news of a potential sale <a href=\"https://seekingalpha.com/news/1930975-intermune-up-on-takeout-rumors\" target=\"_blank\">emerged</a>.</li>\n<li>The deal gives Roche access to pirfenidone, which targets idiopathic pulmonary fibrosis, a disease that causes tissue deep in the lungs to become thick and scarred over time. Analysts <a href=\"http://www.bloomberg.com/news/2014-08-24/roche-holding-agrees-to-buy-intermune-for-8-3-billion.html\" target=\"_blank\">predict</a> pirfenidone will generate $1B in global sales by 2019.</li>\n<li>Pirfenidone joins Roche\u2019s stable of pulmonary treatments, including Pulmozyme for cystic fibrosis, Xolair for asthma, and in-development asthma drug lebrikizumab. Roche plans to speed pirfenidone\u2019s U.S. start-up and help get insurance coverage for the medicine.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1950225\" data-linked=\"Roche to buy InterMune for $8.3B in cash\" data-tweet=\"$RHHBY $RHHBY $RHHBF - Roche to buy InterMune for $8.3B in cash https://seekingalpha.com/news/1950225-roche-to-buy-intermune-for-8_3b-in-cash?source=tweet\" data-url=\"https://seekingalpha.com/news/1950225-roche-to-buy-intermune-for-8_3b-in-cash\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":1,"message":null,"success":true,"today":{"start":1576904400,"end":1576990799,"str":"Saturday, December 21, 2019"},"yesterday":{"start":1576818000,"end":1576904399}}